A109960 Stock Overview
Distributes pharmaceutical products in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
AP Healthcare Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩487.00 |
| 52 Week High | ₩940.00 |
| 52 Week Low | ₩455.00 |
| Beta | 0.80 |
| 11 Month Change | -13.04% |
| 3 Month Change | -31.89% |
| 1 Year Change | -45.59% |
| 33 Year Change | -86.13% |
| 5 Year Change | -84.19% |
| Change since IPO | -91.15% |
Recent News & Updates
Why AP Healthcare's (KOSDAQ:109960) Soft Earnings Are Just The Beginning Of Its Problems
Nov 21
AP Healthcare (KOSDAQ:109960) Is Making Moderate Use Of Debt
Sep 06Shareholder Returns
| A109960 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | 1.2% | -3.0% | 2.3% |
| 1Y | -45.6% | 22.4% | -3.8% |
Return vs Industry: A109960 underperformed the KR Biotechs industry which returned 22.4% over the past year.
Return vs Market: A109960 underperformed the KR Market which returned -3.8% over the past year.
Price Volatility
| A109960 volatility | |
|---|---|
| A109960 Average Weekly Movement | 6.6% |
| Biotechs Industry Average Movement | 8.1% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in KR Market | 11.4% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A109960 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A109960's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 16 | Hui Chang | www.aprogen-hng.com |
AP Healthcare Inc. distributes pharmaceutical products in South Korea. It offers prescription and over-the-counter medication, such as antibiotics, antifungal agent, antiviral drugs, infusion solution, peptic ulcer medication, osteoarthritis treatment, purifying solvent, brain function improvement agent, respiratory solvent, topical medicine, adrenocorticosteroids, urinary medicine, hair loss treatment, antipyretic analgesic and anti-inflammatory agent, antihistamines, obesity agents, neural contract, liver extract, fire extinguisher solvent, etc. The company was formerly known as Aprogen Healthcare & Games Inc. and changed its name to AP Healthcare Inc. in April 2024. AP Healthcare Inc. was founded in 1998 and is headquartered in Seongnam-si, South Korea.
AP Healthcare Inc. Fundamentals Summary
| A109960 fundamental statistics | |
|---|---|
| Market cap | ₩97.77b |
| Earnings (TTM) | ₩16.12b |
| Revenue (TTM) | ₩16.03b |
6.1x
P/E Ratio6.1x
P/S RatioIs A109960 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A109960 income statement (TTM) | |
|---|---|
| Revenue | ₩16.03b |
| Cost of Revenue | ₩10.70b |
| Gross Profit | ₩5.32b |
| Other Expenses | -₩10.80b |
| Earnings | ₩16.12b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 80.30 |
| Gross Margin | 33.22% |
| Net Profit Margin | 100.58% |
| Debt/Equity Ratio | 5.1% |
How did A109960 perform over the long term?
See historical performance and comparison